NATASHA WERTH: Open Payments
NPI 1124652441 · HAYS, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$363 in 17 payments from 7 companies in 2025. Trend: 2023 $223 · 2024 $377 · 2025 $363
Food & beverage: $363
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $148 |
| Amgen Inc. | 3 | $59 |
| Novo Nordisk Inc | 2 | $52 |
| Lilly USA, LLC | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: VRAYLAR, QULIPTA, Wegovy, EVENITY, REXULTI, REPATHA, ZEPBOUND, MOUNJARO.
Industry payments across KS — which companies pay providers there.
